NRX Pharmaceuticals, Inc. (NRXP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6294442099
NRX Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.23 m USD |
| Gross profit | 720,000.00 USD |
| Operating income | -16.22 m USD |
| EBIT | -27.96 m USD |
| Net income | -28.62 m USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.
More stocks
- XL Holdings Bhd (7121.KL)
- Shutterstock, Inc. (SSTK)
- BEYOND MEAT, INC. (BYND)
- Maxigen Biotech Inc (1783.TW)
- Era Media Sejahtera (DOOH.JK)
- LIG-ES SPAC (220260.KQ)
- HE Group Berhad (0296.KL)
- UMeWorld Inc. (UMEW)
- SolarWindow Technologies, Inc. (WNDW)
- Farcent Enterprise Co Ltd (1730.TW)
- SOS Lab (464080.KQ)
- CUMBERLAND PHARMACEUTICALS INC (CPIX)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.